124 related articles for article (PubMed ID: 32888170)
1. Patterns of Failure in Triple Negative Breast Cancer Patients in an Urban, Predominately Black Population.
Cherng HR; Rice SR; Hamza M; Murali S; Rosenblatt P; Tkaczuk KHR; Bellavance E; Cheston S; Amin N; Nichols E
J Racial Ethn Health Disparities; 2021 Aug; 8(4):1035-1046. PubMed ID: 32888170
[TBL] [Abstract][Full Text] [Related]
2. Triple-Negative Breast Cancer: A Comparison of Race and Survival.
Doepker MP; Holt SD; Durkin MW; Chu CH; Nottingham JM
Am Surg; 2018 Jun; 84(6):881-888. PubMed ID: 29981619
[TBL] [Abstract][Full Text] [Related]
3. Does race predict survival for women with invasive breast cancer?
Walsh SM; Zabor EC; Stempel M; Morrow M; Gemignani ML
Cancer; 2019 Sep; 125(18):3139-3146. PubMed ID: 31206623
[TBL] [Abstract][Full Text] [Related]
4. Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis.
Perez CA; Zumsteg ZS; Gupta G; Morrow M; Arnold B; Patil SM; Traina TA; Robson ME; Wen YH; McCormick B; Powell SN; Ho AY
Breast Cancer Res Treat; 2013 Jun; 139(2):497-506. PubMed ID: 23645006
[TBL] [Abstract][Full Text] [Related]
5. Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.
Sheppard VB; Cavalli LR; Dash C; Kanaan YM; Dilawari AA; Horton S; Makambi KH
Clin Breast Cancer; 2017 Jun; 17(3):232-238. PubMed ID: 28189497
[TBL] [Abstract][Full Text] [Related]
6. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.
Sturtz LA; Melley J; Mamula K; Shriver CD; Ellsworth RE
BMC Cancer; 2014 Feb; 14():62. PubMed ID: 24495414
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutations of triple-negative breast cancer: a comparison between Black and White women.
Omilian AR; Wei L; Hong CC; Bandera EV; Liu S; Khoury T; Ambrosone CB; Yao S
Breast Cancer Res Treat; 2020 Jul; 182(2):503-509. PubMed ID: 32441016
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of triple-negative versus non-triple-negative breast cancers managed with breast-conserving therapy.
Bhatti AB; Khan AI; Siddiqui N; Muzaffar N; Syed AA; Shah MA; Jamshed A
Asian Pac J Cancer Prev; 2014; 15(6):2577-81. PubMed ID: 24761867
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors and patterns of recurrence in patients with triple negative breast cancer.
Steward L; Conant L; Gao F; Margenthaler JA
Ann Surg Oncol; 2014 Jul; 21(7):2165-71. PubMed ID: 24558065
[TBL] [Abstract][Full Text] [Related]
10. Update on triple-negative breast cancer disparities for the United States: A population-based study from the United States Cancer Statistics database, 2010 through 2014.
Scott LC; Mobley LR; Kuo TM; Il'yasova D
Cancer; 2019 Oct; 125(19):3412-3417. PubMed ID: 31282032
[TBL] [Abstract][Full Text] [Related]
11. Biopsychosocial Challenges and Needs of Young African American Women with Triple-Negative Breast Cancer.
Bollinger S
Health Soc Work; 2018 May; 43(2):84-92. PubMed ID: 29481665
[TBL] [Abstract][Full Text] [Related]
12. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
Chen L; Li CI
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.
Cho B; Han Y; Lian M; Colditz GA; Weber JD; Ma C; Liu Y
JAMA Oncol; 2021 Jul; 7(7):1016-1023. PubMed ID: 33983438
[TBL] [Abstract][Full Text] [Related]
14. Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review.
Newman LA; Kaljee LM
JAMA Surg; 2017 May; 152(5):485-493. PubMed ID: 28355428
[TBL] [Abstract][Full Text] [Related]
15. Triple-negative breast cancer in African-American women: disparities versus biology.
Dietze EC; Sistrunk C; Miranda-Carboni G; O'Regan R; Seewaldt VL
Nat Rev Cancer; 2015 Apr; 15(4):248-54. PubMed ID: 25673085
[TBL] [Abstract][Full Text] [Related]
16. Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
Sparano JA; Wang M; Zhao F; Stearns V; Martino S; Ligibel JA; Perez EA; Saphner T; Wolff AC; Sledge GW; Wood WC; Davidson NE
J Natl Cancer Inst; 2012 Mar; 104(5):406-14. PubMed ID: 22250182
[TBL] [Abstract][Full Text] [Related]
17. Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
O'Meara T; Safonov A; Casadevall D; Qing T; Silber A; Killelea B; Hatzis C; Pusztai L
Breast Cancer Res Treat; 2019 May; 175(1):247-259. PubMed ID: 30725384
[TBL] [Abstract][Full Text] [Related]
18. Triple-Negative Breast Cancer, Stem Cells, and African Ancestry.
Jiagge E; Chitale D; Newman LA
Am J Pathol; 2018 Feb; 188(2):271-279. PubMed ID: 29137951
[TBL] [Abstract][Full Text] [Related]
19. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
[TBL] [Abstract][Full Text] [Related]
20. Early breast cancer survival of black and white American women with equal diagnostic and therapeutic management.
Leonard-Murali S; Nathanson SD; Springer K; Baker P; Susick L
Eur J Surg Oncol; 2023 Mar; 49(3):583-588. PubMed ID: 36464602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]